Alpha-9 Oncology

Series-B+
a9oncology.com Biotech & Healthcare Boston, United States Founded 2019 51-100
Total Funding $175M
Latest Round $175M Series-B+
Last Announced Oct 23, 2024
Investors 14 Backers
Decision Makers 6 Verified

About Alpha-9 Oncology

Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that develops targeted radiotherapeutics for cancer treatment. The company creates bespoke molecules to treat cancer cells. Alpha-9 Oncology focuses on solid and hematologic malignancies.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Boston, United States
Year Founded 2019
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website a9oncology.com
Domain Registered Date Aug 24, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $175,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    a9oncology.com

  3. Milestone

    Company founded

    Boston, United States

Investors & Backers

14
Aberdeen
Andreessen Horowitz
Biotechnology Value Fund
Delos Capital
Digitalis Ventures
Frazier Life Sciences
General Catalyst
Janus Henderson Investors
Lightspeed
Longitude Capital
Lumira Ventures
Nextech Invest
RA Capital Management
Samsara Biocapital

Funding History

1 Round
Series-B+ · Oct 23, 2024

Founders & Leadership

6

David Perrin

founder

Work email & phone locked Unlock →

François Bénard

founder

Work email & phone locked Unlock →

Ian McBeath

CEO

Work email & phone locked Unlock →

Kuo-Shyan Lin

founder

Work email & phone locked Unlock →

Paul Blanchfield

Chief Executive Officer

Work email & phone locked Unlock →

Robert Meehan

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts